Angelini C - Search Results

1

Motor neuron disease in the Padua district of Italy: an epidemiological study.

Briani C, Marcon M, Dam M, Beghi E, Pegoraro E, Angelini C. Briani C, et al. Among authors: angelini c. Neuroepidemiology. 1996;15(4):173-9. doi: 10.1159/000109905. Neuroepidemiology. 1996. PMID: 8817499

2

Epidemiology of spinal muscular atrophies in a sample of the Italian population.

Mostacciuolo ML, Danieli GA, Trevisan C, Müller E, Angelini C. Mostacciuolo ML, et al. Among authors: angelini c. Neuroepidemiology. 1992;11(1):34-8. doi: 10.1159/000110905. Neuroepidemiology. 1992. PMID: 1608493

3

Frequency of duplication at 17p11.2 in families of northeast Italy with Charcot-Marie-Tooth disease type 1.

Mostacciuolo ML, Schiavon F, Angelini C, Miccoli B, Piccolo F, Danieli GA. Mostacciuolo ML, et al. Among authors: angelini c. Neuroepidemiology. 1995;14(2):49-53. doi: 10.1159/000109778. Neuroepidemiology. 1995. PMID: 7891814

4

Clinical-molecular correlation in 104 mild X-linked muscular dystrophy patients: characterization of sub-clinical phenotypes.

Angelini C, Fanin M, Pegoraro E, Freda MP, Cadaldini M, Martinello F. Angelini C, et al. Neuromuscul Disord. 1994 Jul;4(4):349-58. doi: 10.1016/0960-8966(94)90071-x. Neuromuscul Disord. 1994. PMID: 7981592

5

Absence of dystrophin and spectrin in regenerating muscle fibers from Becker dystrophy patients.

Fanin M, Pegoraro E, Angelini C. Fanin M, et al. Among authors: angelini c. J Neurol Sci. 1994 May;123(1-2):88-94. doi: 10.1016/0022-510x(94)90208-9. J Neurol Sci. 1994. PMID: 8064327

6

Deflazacort in Duchenne dystrophy: study of long-term effect.

Angelini C, Pegoraro E, Turella E, Intino MT, Pini A, Costa C. Angelini C, et al. Muscle Nerve. 1994 Apr;17(4):386-91. doi: 10.1002/mus.880170405. Muscle Nerve. 1994. PMID: 8170484 Clinical Trial.

7

Reappraisal of the incidence rate of Duchenne and Becker muscular dystrophies on the basis of molecular diagnosis.

Mostacciuolo ML, Miorin M, Pegoraro E, Fanin M, Schiavon F, Vitiello L, Saad FA, Angelini C, Danieli GA. Mostacciuolo ML, et al. Among authors: angelini c. Neuroepidemiology. 1993;12(6):326-30. doi: 10.1159/000110334. Neuroepidemiology. 1993. PMID: 8309507

8

Duchenne phenotype with in-frame deletion removing major portion of dystrophin rod: threshold effect for deletion size?

Fanin M, Freda MP, Vitiello L, Danieli GA, Pegoraro E, Angelini C. Fanin M, et al. Among authors: angelini c. Muscle Nerve. 1996 Sep;19(9):1154-60. doi: 10.1002/mus.880190902. Muscle Nerve. 1996. PMID: 8761273

9

Myotonia and the muscle chloride channel: dominant mutations show variable penetrance and founder effect.

Koty PP, Pegoraro E, Hobson G, Marks HG, Turel A, Flagler D, Cadaldini M, Angelini C, Hoffman EP. Koty PP, et al. Among authors: angelini c. Neurology. 1996 Oct;47(4):963-8. doi: 10.1212/wnl.47.4.963. Neurology. 1996. PMID: 8857727

10

alpha-Sarcoglycan (adhalin) deficiency: complete deficiency patients are 5% of childhood-onset dystrophin-normal muscular dystrophy and most partial deficiency patients do not have gene mutations.

Duggan DJ, Fanin M, Pegoraro E, Angelini C, Hoffman EP. Duggan DJ, et al. Among authors: angelini c. J Neurol Sci. 1996 Sep 1;140(1-2):30-9. doi: 10.1016/0022-510x(96)00028-7. J Neurol Sci. 1996. PMID: 8866424

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,040 results

Search Page

Filters